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Objective: The	2014	update	of	 the	Swiss	 law	on	 research	 increases	patients'	pro-
tection;	 it	adds	specific	 requirements	 for	emergency	situations,	 implying	an	active	
search	for	patients'	wishes	regarding	research	participation;	the	possibility	of	con-
sent waivers is not clearly stated. We explored its practical impact in a RCT on criti-
cally ill adults.




and the yield of retrieving statements on willingness to research participation. We 








Conclusions: Consent waivers should be specifically foreseen to prevent losing a 
potentially	 relevant	 proportion	of	 patients	 reaching	 endpoints,	 and	 ensure	 results	
generalizability.	The	yield	of	looking	for	willingness	to	research	participation	seems	
low; this questions its current usefulness and calls for a public awareness campaign.














































































search on critically ill patients or in emergency situations is essential to 
attempt	decreasing	the	related	morbidity	and	mortality,	but	this	popu-
lation cannot be easily involved; specific regulations exist in these set-
tings	(Federal	Act	on	Research	involving	Human	Beings,	2011b,	2011c).




sibility to obtain specific consent waivers is not explicitly described 
(EC	may	nevertheless	grant	 these,	 in	practice),	a	patient's	statement	
regarding willingness or opposition to participate to clinical research 




cially	 for	critically	 ill	patients.	 Ideally,	a	written	note	should	be	 iden-






should obtain at inclusion a statement by an independent physician 
with	 the	 fiduciary	duty	of	safeguarding	patients'	 interests.	 Informed	





depends on subjective appreciation.
To	our	knowledge,	application	of	the	current	Swiss	rules	regard-
ing research in emergency situations and patients unable to consent 
has not been explored; this aspect has received limited attention 
also in other settings. This work describes the process of informed 




2.1 | Patients and clinical context
Nonconvulsive	 (subclinical)	 seizures	and	status	epilepticus	 (SE)	are	
frequent	 in	 comatose	 patients,	 and	 associated	 with	 considerable	
morbidity	and	mortality	(Towne	et	al.,	2000;	Zehtabchi	et	al.,	2013).	
Continuous	EEG	(cEEG)	improves	nonconvulsive	seizures	and	SE	de-
tection	compared	with	routine	EEG	(rEEG)	lasting	<30 min (Claassen 
et	 al.,	 2004)	 and	 is	 broadly	 recommended	 in	 critically	 ill	 patients	
(Claassen	 et	 al.,	 2013;	 Herman	 et	 al.,	 2015a,	 2015b).	 However,	
the	 effect	 on	 outcome	 remains	 unclear.	 CERTA	 (Continuous	 EEG	
Randomized	 Trial	 in	Adults,	NCT03129438)	 (Rossetti	 et	 al.,	 2018)	
aimed	to	determine	whether	cEEG	in	adults	with	consciousness	im-
pairment	 correlated	with	 a	 better	 outcome	 than	 rEEG.	 It	 involved	
four	 large	 Swiss	 hospitals	 (CHUV	 Lausanne;	 Hôpital	 du	 Valais;	
Inselspital	Bern;	Universitätsspital	Basel).	Between	April	2017	and	
November	2018,	adults	with	acute	consciousness	impairment	in	an	
intensive/intermediate	 care	 unit	 needing	 an	 EEG	 for	 clinical	 pur-





tory procedures were verified by an independent monitor.
2.2 | Procedures and variables
We	 retrospectively	 analyzed	 the	 consent	 procedure	 of	 recruited	
subjects,	which	 occurred	 under	 the	 current	 Swiss	 law.	Before	 en-
rollment,	 a	 statement	had	 to	be	always	 signed	by	an	 independent	
physician.	 If	 the	 patient	 recovered	 judgment	 capacity,	 a	 post	 hoc	
consent	had	to	be	sought	within	the	6-month	follow-up.	In	the	suba-
cute	period,	if	this	was	impossible	after	one	week	(±3 days; defined 
for this study as the time when judgment capacity was considered 
“permanently”	lacking,	considering	a	compromise	between	the	end	





(without quantitative cognitive assessments) and obtain a post hoc 
consent.	If	consent	was	refused	by	proxy	or	the	patient,	all	collected	
data	 had	 to	 be	 discarded.	 Under	 predefined	 conditions,	 however,	
in view of the minimal risks related to participation to this RCT felt 
to be negligible as compared to the potential collective benefit (as-
sessing	a	biological	surveillance	but	not	a	therapeutic	intervention),	
waivers	specific	for	this	study	were	obtained	from	the	EC,	to	allow	
enrolling patients and using clinical data despite lack of informed 




sustaining therapy was made (to prevent additional distress to the 
family); d—a patient died before proxy consent was collected (idem); 
e—an oral agreement was provided to an investigator accompanied 
by	a	caregiver	witness,	unrelated	to	the	study.
Demographical,	 administrative	 (statement	 of	 wishes,	 authori-
zation	 from	 independent	 physicians,	 informed	 consents	 obtained	
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or	 refused/	 withdrawn,	 state	 of	 capacity	 to	 consent),	 and	 clinical	
information was prospectively collected for the trial. We assessed 
the	 proportion	 of	 consents	 obtained	 in	 accordance	 with	 the	 law,	
determined the proportion obtained directly from the patient or 
from	a	proxy,	and	the	proportion	of	patients,	proxy,	or	legal	repre-
sentative	consent	refusals	or	withdrawals,	stratified	for	study	inter-
vention. We also assessed exceptions in which data were collected 
according	 to	EC-granted	waivers.	We	compared	 the	proportion	of	
consent	refusals	and	withdrawals	obtained	in	the	CERTA	study	with	








We present descriptive statistics; frequencies were tested using 
2-sided	Fisher's	exact	tests	using	STATA	version	14.
3  | RESULTS
The	 trial	 included	 402	 adults	 with	 acute	 consciousness	 disorders	
hospitalized	 in	an	 intensive/intermediate	care	unit	of	the	four	par-
ticipating	hospitals;	201	each	received	cEEG	and	rEEG.	Seven	(1.7%)	
patients	were	 excluded	 early	 (six	were	 included	 twice,	 one	 death	
prior	 to	 intervention),	 and	 data	 from	 27	 (6.7%)	 additional	 partici-





Four	 patients	were	 lost	 to	 follow-up,	 but	 clinical	 information	was	
available	only	until	the	4th	week	(Figure	1).
The	 main	 results	 are	 summarized	 in	 Figure	 1	 and	 Table	 1.	
Written	 authorizations	 from	 an	 independent	 physician	 were	 col-
lected	before	inclusion	in	all	368	analyzable	patients.	A	clear	state-
ment regarding willingness to research participation was found in 
52/368	(14.1%)	of	analyzable	patients,	mostly	retrieved	orally	from	
a proxy (Table 2) after repeated attempts in an emergency/critical 
situation.	Again,	 there	were	no	differences	across	 recruiting	 cen-
ters.	Of	relevance,	134	patients	(36.4%)	remained	in	the	study	and	
their	data	were	analyzed	in	the	absence	of	any	consent,	according	
to the predefined waivers (Table 1). Data following consent refusals 










We	 further	 analyzed	 the	 type	of	 the	110	waivers	 collected	 in	 the	
CHUV	(details	on	the	waivers	in	other	hospitals	were	not	available;	
Figure 3): consent was lacking mostly because of care withdrawal or 
early	death.	In	five	cases	(4.5%),	the	form	was	missing,	but	a	docu-
mented,	witnessed	oral	consent	was	obtained.
Proportions of consent refusals or withdrawals in recent studies 
involving	critically	 ill	patients	vary	 from	0%	to	23.2%	 (Table	3),	al-
though detailed information is at times lacking in the papers.
CHUV (318 
patients)




Patients excluded because double 
inclusions or death before intervention
6	(1.9%) 1	(1.2%) 1.000
Patient's	data	analyzable 289	(92.6%) 79	(95.2%) .624
Patient's	post	hoc	consent 61	(19.6%) 16	(19.3%)




Waiver	according	to	the	EC 110	(35.3%) 24	(28.9%) .480
Patient's	data	not	analyzable 23	(7.4%) 4	(4.8%) .624
Patient's	post	hoc	consent	refusal 12	(3.8%) 1	(1.2%)
Proxy consent refusal 8	(2.6%) 3	(3.2%)
Patient's	consent	default 1	(0.3%) 0
Proxy consent default 2	(0.6%) 0 .576
Note: Consent default means not receiving the consent form from a patient or proxy (who did not 
decline	participation),	and	impossibility	to	apply	a	waiver	as	defined	by	the	EC.
Abbreviation:	EC,	Ethics	Commission.
TA B L E  1   Distribution of the data 
among the different sites (column 
percentages);	7	patients	that	were	
excluded early are not reported
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F I G U R E  1  Study	participants'	flow	diagram
CHUV (289 
patients)




Total per site 38	(13.1%) 14	(17.7%) 0.361
Source
Relative or legal 
representative
36	(12.5%) 14	(17.7%)
Patient's	medical	file 2	(0.7%) 0 1.000
TA B L E  2  Source	of	statement	of	
wishes	among	analyzable	patients	(column	
percentages)
F I G U R E  2   Capacity of consent 
recovery through the different 
assessment time points. The number 
of patients regaining their capacity of 
consent during the mentioned period is 
illustrated	in	dark	gray,	and	the	number	
of patients who already recovered their 
judgment is in light gray. The whole 
column represents the total of patients 
able	to	consent	at	the	respective	time-
point
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4  | DISCUSSION
While research on critically ill patients is needed to improve their 
prognosis	 (Luce	et	al.,	2004),	 it	 is	generally	difficult	 to	 involve	this	
vulnerable	population	in	research.	This	assessment	of	a	randomized	
trial on adults with acute consciousness impairment shows that data 
were	available	for	analysis	in	accordance	with	the	EC	requirements	
in	more	 than	 90%	 of	 enrolled	 patients.	 However,	 ad	 hoc	waivers	
granted	 by	 the	 EC	 allowed	 analysis	 of	 more	 than	 1/3	 of	 patients	
lacking	informed	consent.	It	was	possible	to	identify	a	statement	of	
wishes reporting willingness to participate to clinical research in less 
than	1/7	of	patients	(almost	never	in	patients’	charts).	Finally,	con-
sent	was	refused	or	withdrawn	in	nearly	7%	of	enrollments,	and	data	
had to be discarded.
The time beyond which lack of consent capacity was considered 
as	 permanent	 was	 preset	 at	 7	 (±3)	 days	 (EEG	 interventions	 were	




retrospectively	 corroborates	 this	 time	 point.	 During	 follow-up,	
investigators	 repeatedly	 tried	 to	define	 the	patient's	 judgment	ca-
pacity and to obtain post hoc consents: several attempts had to be 
carried	out	per-protocol,	but,	unfortunately,	no	details	on	this	pro-
cedure were collected.
Initial	 steps	 complied	 with	 the	 current	 Swiss	 regulatory	 re-
quirements:	 for	 each	 analyzable	 patient,	 we	 obtained	 consent	
from	 independent	 physicians.	 Informed	 consents	were	 obtained	
in	 approximately	 2/3	 of	 analyzable	 patients,	 more	 frequently	
by proxy; this occurred despite the possible stress related to 





EC	 allowed	waivers	 in	 particular	 situations,	 and	 finally	 informed	
consent	 was	 waived	 in	 36%	 of	 analyzable	 patients,	 mostly	 be-
cause	of	 intensive	care	withdrawal	or	early	death.	Of	 relevance,	
strictly	applying	the	Swiss	law,	most	of	these	patients	would	have	
been excluded from analysis. This large percentage underlines the 
F I G U R E  3  Proportions	of	the	different	types	of	waivers	in	the	absence	of	informed	consent	CHUV
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paramount importance to carefully define these conditions during 





allowed to waive proxy consent in emergency situations: waiving 




















available in medical files. These observations raise the question 
about	the	relevance	of	repeated	efforts	to	look	for	these	wishes,	to	
be balanced against potential benefits of the implementation of an 
awareness campaign on research (similar to organ transplantation). 
Further,	“signs	and	symptoms	showing	patient's	opposition”	repre-
sent in our view vague concepts not applicable in practice.
While	 the	 proportion	 of	 6.7%	 excluded	 due	 to	 consent	 issues	
seems	relatively	small	at	first	glance,	it	may	exert	an	effect	in	terms	
of study results: as refusals occurred only in survivors (data of pa-
tients	dying	early	was	managed	through	waivers),	mortality	increased	
in	the	analyzed	sample.	Moreover,	since	no	analysis	of	these	patients	
TA B L E  3   Proportion of consent refusals and withdrawals in various studies
Study Country Informed consent process
Study 
participants





written informed consent and 






France Participation without informed 
consent	(standard	of	care),	






consent obtained in a second time 







from the emergency physician 
before	the	enrollment.	Patient's	








physician before the enrollment. 
Patient's	post	hoc	written	consent	







consent obtained in a second time 







consent and subsequently from 








studies in similar settings and allow at least partial use of data from 
these	patients,	 in	order	to	ensure	results’	generalizability.	 In	fact,	a	
recent Canadian study involving critically ill patients showed that 
those	with	consent	refusals	were	the	most	severely	 ill	 (Tropolovec-
Vranic	et	al.,	2014),	while	in	our	study	only	alive	patients	could	refuse.	
Rates of refusals or withdrawals appear much lower when formal 
consent is not required due to general waivers in emergency situa-
tions	(Kapur	et	al.,	2019),	where	often	the	only	requirement	is	to	in-







probably related to different regulations and study designs.
A	recent	US	assessment	focusing	on	emergency	conditions	iden-








ers for the emergency use of a test article in determined situations 
(21CFR 50 and 21CFR56); they also provide for waiver of informed 









study: consent has to be sought as long as a patient is in the study). 
Additionally,	 the	need	to	actively	 look	for	a	previous	statement	of	
wishes and the lack of explicit phrasing regarding possible consent 
waivers	in	emergency	situations	seems	peculiar	for	Switzerland.
Although	we	 analyzed	 a	 prospectively	 collected	 set	 of	 data,	




not specifically powered for this analysis (but tailored for identi-
fication	of	mortality	differences	across	EEG	intervention	groups).	
Consent	 capacity	 was	 not	 evaluated	 quantitatively.	 Finally,	 this	
study	 is	 not	 automatically	 applicable	 to	 a	 pediatric	 population,	
where	 regulatory	 requirements	 may	 differ	 significantly,	 and	 in	
places	outside	Switzerland.	We	however	believe	that	since	Swiss	
regulations	 closely	 follow	 the	 Declaration	 of	 Helsinki	 (World	





due to lack of informed consent; this influenced the primary end-
point	(mortality).	Furthermore,	more	than	1/3	of	recruited	subjects,	
mostly	dying	early,	 could	be	 included	and	analyzed	only	 following	







achieve high ethical standards in research with participants unable 
to	consent	in	emergency	setting.	Such	efforts	should	be	considered	
when	assessing	the	value	of	studies,	beyond	statistical	results,	par-
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